跳至主要内容
临床试验/NCT01022840
NCT01022840已完成3 期

The Opioid Sparing Effect of Minimal Dose S-Ketamine Applied as a Coanalgesic During the Perioperative Period - An Active Placebo-Controlled, Double Blinded, Randomized Clinical Trial (МiniKet)

Medical University of Graz2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60
试验地点
2
主要终点
postoperative opioid consumption

研究概览

简要总结

The primary hypothesis is improved postoperative analgetic quality using S-Ketamine, particularly in patients suffering from chronic pain.

详细描述

The investigators are dealing mainly with the finding of the right dosage for the optimal safety and efficacy of S-Ketamine, but also discovering new possible areas of investigation (e.g. anti-depressive effect, anti-neuropathic effect).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for major abdominal surgery
  • Suitable for PCA
  • Cardio-vascular stable
  • Between 50-120kg BW
  • Good Compliance for pain monitoring

排除标准

  • Allergy to S-Ketamine
  • Severe liver or kidney dysfunction
  • Severe coronary disease
  • Pregnancy
  • Present or past psychotic disorders
  • Addiction to alcohol or opioids
  • Poor compliance

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo as saline solution

干预措施: Placebo Comparison (Other)

Low dose

Experimental

S-Ketamine

干预措施: S-Ketamine (Drug)

High dose

Active Comparator

干预措施: S-Ketamine (Drug)

结局指标

主要结局

postoperative opioid consumption

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
Medical University of Graz
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andreas Sandner-Kiesling , MD

Univ. Prof. Dr.

Medical University of Graz

研究点 (2)

Loading locations...

相似试验